The Malaghan Institute is one step closer to its goal of making CAR T-cell therapy a standard of care in New Zealand as its phase 2 clinical trial opens its doors in Christchurch and Auckland City ...

The Malaghan Institute is one step closer to its goal of making CAR T-cell therapy a standard of care in New Zealand as its phase 2 clinical trial opens its doors in Christchurch and Auckland City ...

Few advancements in contemporary medicine have sparked as much enthusiasm and potential as CAR T-cell therapy.

The ASX has begun February's final week in the red, while WiseTech has tanked after four execs quit the company. ... Read ...

Detailed price information for Cero Therapeutics Holdings Inc (CERO-Q) from The Globe and Mail including charting and trades.

FDA approves vimseltinib for tenosynovial giant cell tumor and a triplet for R/R LBCL, plus the latest from ASCO GU 2025.

In Lent, don’t just give up, take up. Take up prayer, fasting and alms-giving. Give up sin and take up repentance.